[Guest post] Dramatic reversal in the CRISPR Broad Institute cases following G 1/22
http://ipkitten.blogspot.com/2024/03/guest-post-dramatic-reversal-in-crispr.html In G 1/22 (and G 2/22), the Enlarged Board of Appeal (EBA) found that there is a strong rebuttable presumption that an applicant of a European patent application is entitled to claim priority. An interesting question following G 1/22 was the potential impact (if any) on the high-profile CRISPR dispute. The Broad Institute famously... Continue reading